EP3038465
ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.8.2014EP published:
6.10.2021EP application number:
14840833.9
EPO information:
European Patent Register
Max expiry date:
24.8.2034
Title:
ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN
Timeline
Today
25.8.2014EP application
6.10.2021EP Publication
Owner
Name:
Merck Sharp & Dohme Corp.Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, US
Name:
Merck Sharp & Dohme LimitedAddress:
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, GB
Inventor
Name:
COOPER, Vincent, BrettAddress:
Cheshunt Hertfordshire EN8 9HH, GB
Name:
BRADLEY, Kathryn, AlannaAddress:
St. Albans Hertfordshire AL1 1UU, GB
Name:
PYGALL, Samuel, RobertAddress:
Hoddesdon Hertfordshire EN11 9BU, GB
Name:
GUPTA, RajanAddress:
Cary, NC 27519, US
Name:
STANFORD, Madison, PaigeAddress:
Summit, NJ 07901, US
Name:
XIE, LinAddress:
Summit, NJ 07901, US
Priority
Number:
201361871951 PDate:
30.8.2013Country:
US
Classification
Categories:
A61K 9/20, A61K 31/4162, A61P 3/10, A61K 9/28